DISEASE SCANNER
Global Incurable Diseases Tracker
Homocystinuria
A group of autosomal recessive disorders affecting methionine metabolism. Most common form is cystathionine beta-synthase deficiency. Characterized by lens dislocation, intellectual disability, thromboembolism, and skeletal abnormalities. Responds to pyridoxine (B6) in some patients.
80.0K
18
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Newborn screening
- 2Plasma total homocysteine
- 3Methionine levels
- 4Genetic testing
- 5Ophthalmologic examination
Prognosis
B6-responsive forms have better prognosis. Untreated: thromboembolism, lens dislocation by age 10, intellectual disability. Early treatment prevents complications.
Prevention
- Newborn screening
- Genetic counseling
- Prenatal diagnosis
- Anticoagulation when needed
- Regular monitoring
Research Status
Pyridoxine (B6) supplementation (responsive patients) and Methionine-restricted diet are primary treatments. Research focuses on improved therapies and outcomes.
Affected Countries
Sources
- https://rarediseases.org/rare-diseases/homocystinuria
- https://www.nichd.nih.gov/health/topics/homocystinuria
- https://www.ncbi.nlm.nih.gov/books/NBK1524
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.